Warkad Vivekanand U, Hunter David G, Dagi Alexander F, Mackinnon Sarah, Kazlas Melanie A, Heidary Gena, Staffa Steven J, Dagi Linda R
From the Department of Ophthalmology (V.U.W., D.G.H., S.M., M.A.K., G.H., L.R.D.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Department of Plastic and Oral Surgery (A.F.D.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Ophthalmol. 2022 May;237:83-90. doi: 10.1016/j.ajo.2021.11.006. Epub 2021 Nov 13.
To describe outcomes after treatment of Moebius syndrome (MBS) esotropia by adjustable bilateral medial rectus recession (BMR) with and without augmented superior rectus transposition (SRT).
Retrospective case series.
Patients meeting 2014 diagnostic criteria for MBS and treated at Boston Children's Hospital between 2003 and 2019 were identified via billing records and chart review. Visual acuity, sensorimotor evaluations, strabismus procedures, and other clinical features were recorded. Surgical outcomes for patients treated with strabismus surgery (excluding those with prior surgery elsewhere) were evaluated. The primary outcome measure was postoperative alignment comparing treatment by adjustable BMR vs adjustable BMR+SRT.
A total of 20 patients had MBS, and 12 of these (60%) were male. Fifteen patients (75%) had primary position esotropia, and all had bilateral abduction deficit. Eight of 20 patients met inclusion criteria for primary strabismus surgery outcome. Five had undergone adjustable BMR ranging from 4.5 to 6.5 mm. Three had undergone adjustable BMR+SRT, all with 4-mm medial rectus muscle recessions. Mean preoperative esotropia before treatment by BMR was 39.5 PD (± 15 PD) with mean postoperative esotropia 9 PD (± 7.9 PD) at 6 months. Mean preoperative esotropia before treatment by BMR+SRT was 70.8 PD (± 5.9 PD) with mean postoperative esotropia 2.5 PD (± 3.5 PD) at 6 months. Significantly greater reduction in esotropia resulted from BMR+SRT than from BMR (P = .036).
BMR proved sufficient to treat esotropia <50 PD and BMR+SRT for greater esotropia in patients with MBS-associated abduction limitation.
描述采用可调节双侧内直肌后徙术(BMR)联合或不联合增强型上直肌转位术(SRT)治疗先天性眼球运动不能综合征(MBS)所致内斜视后的疗效。
回顾性病例系列研究。
通过计费记录和病历审查,确定2003年至2019年期间在波士顿儿童医院接受治疗且符合2014年MBS诊断标准的患者。记录视力、感觉运动评估、斜视手术及其他临床特征。评估接受斜视手术患者(不包括之前在其他地方接受过手术的患者)的手术疗效。主要观察指标是比较可调节BMR与可调节BMR+SRT治疗后的术后眼位矫正情况。
共有20例患者患有MBS,其中12例(60%)为男性。15例患者(75%)存在原在位内斜视,且均有双侧外展受限。20例患者中有8例符合原发性斜视手术疗效纳入标准。5例接受了4.5至6.5毫米的可调节BMR。3例接受了可调节BMR+SRT,均进行了4毫米的内直肌后徙。BMR治疗前平均术前内斜视度数为39.5三棱镜度(±15三棱镜度),术后6个月平均内斜视度数为9三棱镜度(±7.9三棱镜度)。BMR+SRT治疗前平均术前内斜视度数为70.8三棱镜度(±5.9三棱镜度),术后6个月平均内斜视度数为2.5三棱镜度(±3.5三棱镜度)。BMR+SRT导致的内斜视度数降低显著大于BMR(P = 0.036)。
对于MBS相关外展受限患者,BMR足以治疗内斜视度数<50三棱镜度的情况,而BMR+SRT可用于治疗内斜视度数更大的情况。